Senvelgo (Velagliflozin Oral Solution, 15 mg/mL) is a novel medication specifically formulated to treat diabetes mellitus in cats. The active ingredient, velagliflozin, works by inhibiting the sodium-glucose co-transporter 2 (SGLT2), which reduces the reabsorption of glucose in the kidneys, causing excess glucose to be excreted in the urine. This helps lower blood glucose levels in diabetic cats.
Senvelgo is typically used in conjunction with insulin therapy to enhance blood sugar control and provide an additional treatment option for diabetic cats. The oral solution is easy to administer, and its targeted action helps to improve the overall management of diabetes, addressing common symptoms such as increased thirst and urination, weight loss, and lethargy.
Veterinary supervision is essential to monitor blood glucose levels and adjust the dosage for optimal treatment outcomes. With Senvelgo, diabetic cats can achieve more stable blood sugar levels, improving their overall health and quality of life.
Dog
Cat
Horse
Livestock & Farm Care
Sea Animal
Small Mammal
Reptile
Bird
